Clinical trial
Tenecteplase Before inteRhospital Transfer for Endovascular Treatment in pAtientS With acUte Anterior ciRculation Large vEssel Occlusion at 4.5 to 24 Hours
NCT07253181 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tenecteplase Before inteRhospital Transfer for Endovascular Treatment in pAtientS With acUte Anterior ciRculation Large vEssel Occlusion at 4.5 to 24 Hours
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- January 6, 2026
- Completion date
- March 30, 2028
- Enrollment
- 572 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke, large vessel occlusion, transportation of patients